A Case of Drug-Induced Aseptic Meningitis Caused by Rozanolixizumab in a Patient With Myasthenia Gravis
Rozanolixizumab, a novel therapeutic medication for myasthenia gravis (MG), is a humanized monoclonal antibody against the neonatal Fc receptor. Sold under the brand name Rystiggo, it is the first treatment that the U.S. Food and Drug Administration has approved for adults with MG positive for eithe...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American College of Physicians
2025-04-01
|
| Series: | Annals of Internal Medicine: Clinical Cases |
| Online Access: | https://www.acpjournals.org/doi/10.7326/aimcc.2024.0238 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!